Recent experience of acute drug toxicity and withdrawal linked to an emerging illicit drug adulterant, medetomidine, has been reported in multiple places. The presentation will discuss the pharmacologic mechanism of the drug, acute toxicity, and complicated withdrawal syndrome which has led to ~90% of patients being admitted to the ICU. I will present treatment recommendations as developed with direct patient care and collaboration with academic colleagues at other sites.
Continuing Medical Education (CME) Credits Available
Participants in this program may earn the following CME credits:
✔ 1 AOA Category 1-A Credit✔ 1 AMA PRA Category 1 Credit™✔ 1 AAPA Category 1 CME Credit ✔ 1 Nurses CNE Credit
Earn valuable continuing education credits while enhancing your professional knowledge!